Objective and design: The use of proton pump inhibitors in acid-related diseases such as peptic ulcer or erosive reflux oesophagitis is well established. The aim of the current nationwide, multicentre ...

Reducing the damage sustained by the heart during a myocardial infarction remains one of the major challenges in cardiology, ...

Many patients hospitalized with severe heart failure are receiving potentially harmful treatment with intravenous fluids, a study has found. Heart failure patients are commonly treated with diuretics ...

ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial PURPOSE: PV701, a ...

Last week, the Australian Therapeutic Goods Administration added intravenous (IV) fluids to the growing list of medicines in short supply. The shortage is due to higher-than-expected demand and ...

Hospital systems across the country — including those in North Texas — are conserving IV fluids as the country's largest manufacturer recovers from damage due to Hurricane Helene. Hospitals across ...